Dr. Stacpoole is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 SW Archer Rd
Gainesville, FL 32610
Education & Training
- Vanderbilt University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1980
- Vanderbilt University Medical CenterResidency, Internal Medicine, 1976 - 1978
- Vanderbilt University School of MedicineClass of 1976
- UC San FranciscoPhD, Pharmacology, 1968 - 1972
Certifications & Licensure
- CA State Medical License 1980 - Present
- FL State Medical License 1981 - 2025
- TN State Medical License 1978 - 1984
Awards, Honors, & Recognition
- Elected Member Royal Society of Physicians, 2000
- Elected Member The American Society for Clinical Investigation, 1985
Clinical Trials
- Prevention of Dichloroacetate Toxicity Start of enrollment: 2001 Sep 01
- Phase III Trial of Coenzyme Q10 in Mitochondrial Disease Start of enrollment: 2007 Jan 01
- Pharmacotoxicology of Trichloroethylene Metabolites Start of enrollment: 2011 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 87 citationsPrimed, constant infusion with [2H3]serine allows in vivo kinetic measurement of serine turnover, homocysteine remethylation, and transsulfuration processes in human o...Jesse F. Gregory, Geraldine J. Cuskelly, Barry Shane, John P. Toth, Thomas G. Baumgartner
The American Journal of Clinical Nutrition. 2000-12-01 - 245 citationsTherapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.Peter W. Stacpoole
Journal of the National Cancer Institute. 2017-11-01 - 40 citationsDefects in the E2 lipoyl transacetylase and the X-lipoyl containing component of the pyruvate dehydrogenase complex in patients with lactic acidemia.Brian H. Robinson, N MacKay, R Petrova-Benedict, I Ozalp, T Coskun
The Journal of Clinical Investigation. 1990-06-01
Grant Support
- Phase 3 Trial Of Coenzyme In Mitochondrial DiseaseFood And Drug Administration2006–2011
- Planning Grant For Phase 3 Trial Of Dichloroacetate In PDH DeficiencyEunice Kennedy Shriver National Institute Of Child Health &Human Development2010
- Pharmacotoxicology Of Trichloroethylene MetabolitesNational Institute Of Environmental Health Sciences2006–2010
- UF Clinical And Translational Science AwardNational Center For Research Resources2009
- Pilot Study Of DCA Effects On Human Tyrosine MetabolismNational Center For Research Resources2009
- Dichloroacetate Treatment Of CLA Presenting In InfancyNational Center For Research Resources2009
- CTSA Infrastructure For Pediatric ResearchNational Center For Research Resources2009
- CTSA Infrastructure For Clinical TrialsNational Center For Research Resources2009
- CTSA Infrastructure For AIDS ResearchNational Center For Research Resources2009
- Clinical Trial: The Effect Of Dichloroacetate On Aerobic Function And Work CapacNational Center For Research Resources2008–2009
- Clinical Trial: Dichloroacetate Treatment Of Congenital Lactic AcidosisNational Center For Research Resources2008–2009
- Pharmacotoxicology Of Trichloroethylene MetabolitesNational Center For Research Resources2005–2009
- Dichloroacetate Kinetics, Metabolism And ToxicologyNational Institute Of Environmental Health Sciences1995–2009
- The Effect Of Dichloroacetate On Aerobic Function And Work Capacity InNational Center For Research Resources2005–2007
- Dichloroacetate Treatment Of Congenital Lactic AcidosisNational Center For Research Resources1997–2007
- Institutional CTSA Planning GrantNational Center For Research Resources2006
- Prevention Of Dichloroacetate ToxicityNational Center For Research Resources2004–2005
- Dichloroacetate Treatment Of Congenital Lactic Acidosis*National Center For Research Resources2004–2005
- Dichloroacetate Kinetics And MetabolismNational Center For Research Resources1996–2004
- Pharmacology Of Trichloroethylene MetabolitesNational Institute Of Environmental Health Sciences2000–2002
- Pathobiology &Treatment Of Malaria In AfricaNational Center For Research Resources1999–2001
- Physiology/Cognition--Ritalin In Sleep Deprived StudentNational Center For Research Resources2000
- Treatment Of Congenital Lactic Acidosis With Sodium DichloroacetateNational Center For Research Resources1998–2000
- Evaluation Of DCA As Adjunct Therapy In Severe MalariaNational Institute Of Allergy And Infectious Diseases1997–1999
- Dichloroacetate Kinetics, Metabolism And Human ToxicologyNational Institute Of Environmental Health Sciences1995–1999
- Natural History And Course Of Cerebrotendonous Xanthomatosis (CTX)National Center For Research Resources1995–1997
- Treatment Of Mitochondrial Myopathies With Dichloroacetic AcidNational Center For Research Resources1995–1996
- Nutritional Control Of Intermediary MetabolismNational Institute Of Diabetes And Digestive And Kidney Diseases1988–1991
- Treatment Of Lactic Acidosis With DichloroacetateNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1990
- Regulation Of Human HMG Coa ReductaseNational Heart, Lung, And Blood Institute1985–1988
- Regulation Of Human HMG Coa ReductaseNational Heart, Lung, And Blood Institute1985–1986
Industry Relationships
- Chief Scientific Officer, Praesidio Pharma, LLCFocus on research involving dichloroacetate (DCA) and related compounds2018 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: